Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
News
UCSF QBI Coronavirus Research Group awarded $67.5 million to develop therapies for future pandemics5
May 18, 2022
Dec 16, 2021